BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1737 related articles for article (PubMed ID: 18544359)

  • 1. En bloc esophagectomy reduces local recurrence and improves survival compared with transhiatal resection after neoadjuvant therapy for esophageal adenocarcinoma.
    Rizzetto C; DeMeester SR; Hagen JA; Peyre CG; Lipham JC; DeMeester TR
    J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1228-36. PubMed ID: 18544359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial.
    Omloo JM; Lagarde SM; Hulscher JB; Reitsma JB; Fockens P; van Dekken H; Ten Kate FJ; Obertop H; Tilanus HW; van Lanschot JJ
    Ann Surg; 2007 Dec; 246(6):992-1000; discussion 1000-1. PubMed ID: 18043101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superiority of extended en bloc esophagogastrectomy for carcinoma of the lower esophagus and cardia.
    Hagen JA; Peters JH; DeMeester TR
    J Thorac Cardiovasc Surg; 1993 Nov; 106(5):850-8; discussion 858-9. PubMed ID: 8231207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. En bloc esophagectomy reduces local recurrence and improves survival compared with transhiatal resection after neoadjuvant therapy for esophageal adenocarcinoma.
    Chang KH; McAnena OJ
    J Thorac Cardiovasc Surg; 2009 Jan; 137(1):253; author reply 253-4. PubMed ID: 19154939
    [No Abstract]   [Full Text] [Related]  

  • 5. Factors affecting postoperative course and survival after en bloc resection for esophageal carcinoma.
    Mariette C; Taillier G; Van Seuningen I; Triboulet JP
    Ann Thorac Surg; 2004 Oct; 78(4):1177-83. PubMed ID: 15464466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. En bloc vs transhiatal esophagectomy for stage T3 N1 adenocarcinoma of the distal esophagus.
    Johansson J; DeMeester TR; Hagen JA; DeMeester SR; Peters JH; Oberg S; Bremner CG
    Arch Surg; 2004 Jun; 139(6):627-31; discussion 631-3. PubMed ID: 15197089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vagal-sparing esophagectomy: the ideal operation for intramucosal adenocarcinoma and barrett with high-grade dysplasia.
    Peyre CG; DeMeester SR; Rizzetto C; Bansal N; Tang AL; Ayazi S; Leers JM; Lipham JC; Hagen JA; DeMeester TR
    Ann Surg; 2007 Oct; 246(4):665-71; discussion 671-4. PubMed ID: 17893503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.
    Pennathur A; Luketich JD; Landreneau RJ; Ward J; Christie NA; Gibson MK; Schuchert M; Cooper K; Land SR; Belani CP
    Ann Thorac Surg; 2008 Jun; 85(6):1930-6; discussion 1936-7. PubMed ID: 18498797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is extended volume external beam radiation therapy covering the anastomotic site beneficial in post-esophagectomy high risk patients?
    Yu E; Dar R; Rodrigues GB; Stitt L; Videtic GM; Truong P; Tomiak A; Ash R; Brecevic E; Inculet R; Malthaner R; Vincent M; Craig I; Kocha W; Lefcoe M
    Radiother Oncol; 2004 Nov; 73(2):141-8. PubMed ID: 15542160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival in lymph node negative adenocarcinoma of the esophagus after R0 resection with and without neoadjuvant therapy: evidence for downstaging of N status.
    Leers JM; Ayazi S; Hagen JA; Terterov S; Klipfel N; Oezcelik A; Abate E; Lipham JC; DeMeester SR; Banki F; DeMeester TR
    J Am Coll Surg; 2009 Apr; 208(4):553-6. PubMed ID: 19476789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant chemoradiation versus chemotherapy for patients undergoing esophagectomy for esophageal cancer.
    Luu TD; Gaur P; Force SD; Staley CA; Mansour KA; Miller JI; Miller DL
    Ann Thorac Surg; 2008 Apr; 85(4):1217-23; discussion 1223-4. PubMed ID: 18355499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of long-term survival after resection of esophageal carcinoma with nonregional nodal metastases.
    Lee PC; Port JL; Paul S; Stiles BM; Altorki NK
    Ann Thorac Surg; 2009 Jul; 88(1):186-92; discussion 192-3. PubMed ID: 19559222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local recurrence after total or subtotal esophagectomy for esophageal cancer.
    Blewett CJ; Miller JD; Ramlawi B; Young JE; BennettWF ; Urschel JD
    J Exp Clin Cancer Res; 2001 Mar; 20(1):17-9. PubMed ID: 11370823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical biology and surgical therapy of intramucosal adenocarcinoma of the esophagus.
    Oh DS; Hagen JA; Chandrasoma PT; Dunst CM; Demeester SR; Alavi M; Bremner CG; Lipham J; Rizzetto C; Cote R; Demeester TR
    J Am Coll Surg; 2006 Aug; 203(2):152-61. PubMed ID: 16864027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. En-bloc esophagectomy for esophageal cancer.
    Tachibana M; Kinugasa S; Yoshimura H; Shibakita M; Tonomoto Y; Dhar DK; Tabara H; Nagasue N
    Am J Surg; 2004 Sep; 188(3):254-60. PubMed ID: 15450830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ten-year survival of esophageal cancer after an en-bloc esophagectomy.
    Oezcelik A; Kaiser GM; Niebel W; Sleyman C; Treckmann JW; Sotiropoulos GC; Reinhardt R; Trarbach T; Malamutmann E; Paul A
    J Surg Oncol; 2012 Mar; 105(3):284-7. PubMed ID: 21953648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant chemotherapy and surgery for esophageal adenocarcinoma: prognostic value of circumferential resection margin and stratification of N1 category.
    Saha AK; Sutton C; Rotimi O; Dexter S; Sue-Ling H; Sarela AI
    Ann Surg Oncol; 2009 May; 16(5):1364-70. PubMed ID: 19252949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modern 5-year survival of resectable esophageal adenocarcinoma: single institution experience with 263 patients.
    Portale G; Hagen JA; Peters JH; Chan LS; DeMeester SR; Gandamihardja TA; DeMeester TR
    J Am Coll Surg; 2006 Apr; 202(4):588-96; discussion 596-8. PubMed ID: 16571425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transhiatal esophagectomy for distal and cardia cancers: implications of a positive gastric margin.
    DiMusto PD; Orringer MB
    Ann Thorac Surg; 2007 Jun; 83(6):1993-8; discussion 1998-9. PubMed ID: 17532385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical T2-T3N0M0 esophageal cancer: the risk of node positive disease.
    Stiles BM; Mirza F; Coppolino A; Port JL; Lee PC; Paul S; Altorki NK
    Ann Thorac Surg; 2011 Aug; 92(2):491-6; discussion 496-8. PubMed ID: 21704291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 87.